These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32731911)

  • 1. Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020.
    Feehan AK; Fort D; Garcia-Diaz J; Price-Haywood EG; Velasco C; Sapp E; Pevey D; Seoane L
    Emerg Infect Dis; 2020 Nov; 26(11):2766-2769. PubMed ID: 32731911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
    Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
    Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA.
    Feehan AK; Velasco C; Fort D; Burton JH; Price-Haywood EG; Katzmarzyk PT; Garcia-Diaz J; Seoane L
    Emerg Infect Dis; 2021 Nov; 27(1):314-7. PubMed ID: 33171096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.
    Mansour M; Leven E; Muellers K; Stone K; Mendu DR; Wajnberg A
    J Gen Intern Med; 2020 Aug; 35(8):2485-2486. PubMed ID: 32495088
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covid-19 antibody tests: a briefing.
    Baraniuk C
    BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020.
    Hallowell BD; Carlson CM; Jacobs JR; Pomeroy M; Steinberg J; Tenforde MW; McDonald E; Foster L; Feldstein LR; Rolfes MA; Haynes A; Abedi GR; Odongo GS; Saruwatari K; Rider EC; Douville G; Bhakta N; Maniatis P; Lindstrom S; Thornburg NJ; Lu X; Whitaker BL; Kamili S; Sakthivel SK; Wang L; Malapati L; Murray JR; Lynch B; Cetron M; Brown C; Roohi S; Rotz L; Borntrager D; Ishii K; Moser K; Rasheed M; Freeman B; Lester S; Corbett KS; Abiona OM; Hutchinson GB; Graham BS; Pesik N; Mahon B; Braden C; Behravesh CB; Stewart R; Knight N; Hall AJ; Killerby ME
    Emerg Infect Dis; 2020 Sep; 26(9):1998-2004. PubMed ID: 32620182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
    Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
    [No Abstract]   [Full Text] [Related]  

  • 14. Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.
    Sutton M; Cieslak P; Linder M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1100-1101. PubMed ID: 32790658
    [No Abstract]   [Full Text] [Related]  

  • 15. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.
    Chen Y; Tong X; Wang J; Huang W; Yin S; Huang R; Yang H; Chen Y; Huang A; Liu Y; Chen Y; Yuan L; Yan X; Shen H; Wu C
    J Infect; 2020 Sep; 81(3):420-426. PubMed ID: 32504745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
    Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
    Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
    [No Abstract]   [Full Text] [Related]  

  • 17. The early antibody response to SARS-Cov-2 infection.
    Dittadi R; Afshar H; Carraro P
    Clin Chem Lab Med; 2020 Sep; 58(10):e201-e203. PubMed ID: 32639941
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.
    Okba NMA; Müller MA; Li W; Wang C; GeurtsvanKessel CH; Corman VM; Lamers MM; Sikkema RS; de Bruin E; Chandler FD; Yazdanpanah Y; Le Hingrat Q; Descamps D; Houhou-Fidouh N; Reusken CBEM; Bosch BJ; Drosten C; Koopmans MPG; Haagmans BL
    Emerg Infect Dis; 2020 Jul; 26(7):1478-1488. PubMed ID: 32267220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic.
    Runkel S; Kowalzik F; Gehring S; Winter J; Grandt CL; Marron M; Seifert-Hitzler S; Hitzler WE
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
    Choe PG; Kang CK; Suh HJ; Jung J; Kang E; Lee SY; Song KH; Kim HB; Kim NJ; Park WB; Kim ES; Oh MD
    Emerg Infect Dis; 2020 Oct; 26(10):2484-2487. PubMed ID: 32579877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.